Gastroesophageal Reflux DiseasePANTHERNCT00561730
Efficacy of Pantoprazole in Patients Older Than 12 Years Who Have Symptoms of Non-Erosive Reflux Disease (NERD) or Erosive Gastroesophageal Reflux Disease (eGERD)
An observational study of Gastroesophageal Reflux Disease, run by Nycomed at 259 sites in Germany.
Trial summary
The aim of the study was to evaluate the effect of 7 days treatment with Pantoprazole 40 mg and 20 mg on symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease) in clinical practice. Read more about this study
- Who is it for?
- Ages 12 years and older
- Conditions the study is for
- Gastroesophageal Reflux Disease
- What is being tested?
- Pantoprazole
- How many people
- 1,995 participants
- Where
- 259 sitesGermany
- Study dates
- Oct 2007to Dec 2008
- Phase
- Observational
- Are there results?
- Yes, posted in the registrySummary in the doctors' view
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 12 years and older
- All sexes
- No healthy volunteers
- Child, Adult, Older adult
Study population: Outpatients
Main inclusion criteria:
- Outpatients with erosive gastro-esophageal reflux disease (eGERD according to Los Angeles classification grade A-D) or non-erosive reflux disease (NERD)
Main exclusion criteria:
- Criteria as defined in the Summary of Product Characteristics (Chapter 4.3)
Trial locations and contacts
259 sites in 1 country.
259 sites in 1 country
Germany259 sites
Nycomed Deutschland GmbH
Aachen, 52078
Nycomed Deutschland GmbH
Ahrensburg, 22926
Nycomed Deutschland GmbH
Alfeld, 31061
Nycomed Deutschland GmbH
Altenburg, 04600
Nycomed Deutschland GmbH
Altenholz, 24161
Nycomed Deutschland GmbH
Ansbach, 91522
Nycomed Deutschland GmbH
Augsburg, 86150
Nycomed Deutschland GmbH
Bad Bederkesa, 27624
Nycomed Deutschland GmbH
Bad Bevensen, 29549
Nycomed Deutschland GmbH
Bad Essen, 49152
Nycomed Deutschland GmbH
Bad Neustadt an der Saale, 97616
Nycomed Deutschland GmbH
Bad Säckingen, 79713
Nycomed Deutschland GmbH
Bad Staffelstein, 96231
Nycomed Deutschland GmbH
Baden-Baden, 76530
Nycomed Deutschland GmbH
Beckum, 59269
Nycomed Deutschland GmbH
Bergisch Gladbach, 51429
Nycomed Deutschland GmbH
Bergkamen, 59192
Nycomed Deutschland GmbH
Berlin, 10318
Nycomed Deutschland GmbH
Berlin, 10437
Nycomed Deutschland GmbH
Berlin, 10713
Nycomed Deutschland GmbH
Berlin, 10719
Nycomed Deutschland GmbH
Berlin, 12043
Nycomed Deutschland GmbH
Berlin, 12587
Nycomed Deutschland GmbH
Berlin, 12627
Nycomed Deutschland GmbH
Berlin, 13125
Nycomed Deutschland GmbH
Berlin, 13187
Nycomed Deutschland GmbH
Bietigheim-Bissingen, 74321
Nycomed Deutschland GmbH
Bitterfeld-Wolfen, 06749
Nycomed Deutschland GmbH
Bodenwerder, 37619
Nycomed Deutschland GmbH
Bonn, 53111
Nycomed Deutschland GmbH
Brakel, 33034
Nycomed Deutschland GmbH
Brandenburg, 14776
Nycomed Deutschland GmbH
Braunschweig, 38100
Nycomed Deutschland GmbH
Bredstedt, 25821
Nycomed Deutschland GmbH
Bremen, 28359
Nycomed Deutschland GmbH
Bremen, 28755
Nycomed Deutschland GmbH
Bremerhaven, 27568
Nycomed Deutschland GmbH
Buedelsdorf, 24782
Nycomed Deutschland GmbH
Butzbach, 35510
Nycomed Deutschland GmbH
Calw, 75365
Nycomed Deutschland GmbH
Castrop-Rauxel, 44577
Nycomed Deutschland GmbH
Chemnitz, 09111
Nycomed Deutschland GmbH
Chemnitz, 09126
Nycomed Deutschland GmbH
Chemnitz, 09127
Nycomed Deutschland GmbH
Chemnitz, 09130
Nycomed Deutschland GmbH
Clausthal-Zellerfeld, 38678
Nycomed Deutschland GmbH
Cloppenburg, 49661
Nycomed Deutschland GmbH
Coburg, 96450
Nycomed Deutschland GmbH
Cölbe, 35091
Nycomed Deutschland GmbH
Cologne, 50679
Nycomed Deutschland GmbH
Cologne, 50999
Nycomed Deutschland GmbH
Cologne, 51065
Nycomed Deutschland GmbH
Cottbus, 03048
Nycomed Deutschland GmbH
Crailsheim, 74564
Nycomed Deutschland GmbH
Darmstadt, 64287
Nycomed Deutschland GmbH
Darmstadt, 64293
Nycomed Deutschland GmbH
Dessau, 06844
Nycomed Deutschland GmbH
Dinkelsbühl, 91550
Nycomed Deutschland GmbH
Dinslaken, 46535
Nycomed Deutschland GmbH
Dortmund, 44269
Nycomed Deutschland GmbH
Dresden, 01067
Nycomed Deutschland GmbH
Dresden, 01127
Nycomed Deutschland GmbH
Dresden, 01187
Nycomed Deutschland GmbH
Dresden, 01307
Nycomed Deutschland GmbH
Eisenach, 99817
Nycomed Deutschland GmbH
Eisenhüttenstadt, 15890
Nycomed Deutschland GmbH
Ellefeld, 08236
Nycomed Deutschland GmbH
Engelskirchen, 51766
Nycomed Deutschland GmbH
Erfurt, 99084
Nycomed Deutschland GmbH
Eschweiler, 52249
Nycomed Deutschland GmbH
Essen, 45138
Nycomed Deutschland GmbH
Essen, 45355
Nycomed Deutschland GmbH
Flensburg, 24939
Nycomed Deutschland GmbH
Frankenberg, 35066
Nycomed Deutschland GmbH
Frankenthal, 67227
Nycomed Deutschland GmbH
Frankfurt, 60389
Nycomed Deutschland GmbH
Freiburg im Breisgau, 79104
Nycomed Deutschland GmbH
Freiburg im Breisgau, 79115
Nycomed Deutschland GmbH
Freising, 85356
Nycomed Deutschland GmbH
Freudenstadt, 72250
Nycomed Deutschland GmbH
Fulda, 36037
Nycomed Deutschland GmbH
Fürth, 90762
Nycomed Deutschland GmbH
Gaggenau, 76571
Nycomed Deutschland GmbH
Garbsen, 30827
Nycomed Deutschland GmbH
Gelsenkirchen, 45884
Nycomed Deutschland GmbH
Genthin, 39307
Nycomed Deutschland GmbH
Gera, 07545
Nycomed Deutschland GmbH
Gera, 07546
Nycomed Deutschland GmbH
Goch, 47574
Nycomed Deutschland GmbH
Göppingen, 73033
Nycomed Deutschland GmbH
Göttingen, 37073
Nycomed Deutschland GmbH
Greiz, 07973
Nycomed Deutschland GmbH
Gresse, 19258
Nycomed Deutschland GmbH
Grevenbroich, 41515
Nycomed Deutschland GmbH
Grevesmühlen, 23936
Nycomed Deutschland GmbH
Güstrow, 18273
Nycomed Deutschland GmbH
Halberstadt, 38820
Nycomed Deutschland GmbH
Halle, 06108
Nycomed Deutschland GmbH
Hamburg, 22115
Nycomed Deutschland GmbH
Hamburg, 22459
Nycomed Deutschland GmbH
Hamburg, 22767
Nycomed Deutschland GmbH
Hanover, 30161
Nycomed Deutschland GmbH
Hanover, 30165
Nycomed Deutschland GmbH
Hanover, 30449
Nycomed Deutschland GmbH
Hardheim, 74736
Nycomed Deutschland GmbH
Harra, 07366
Nycomed Deutschland GmbH
Haßloch, 67454
Nycomed Deutschland GmbH
Hechingen, 72379
Nycomed Deutschland GmbH
Heide, 25746
Nycomed Deutschland GmbH
Henstedt-Ulzburg, 24558
Nycomed Deutschland GmbH
Herford, 32049
Nycomed Deutschland GmbH
Herne, 44623
Nycomed Deutschland GmbH
Herne, 44649
Nycomed Deutschland GmbH
Herrieden, 91567
Nycomed Deutschland GmbH
Hildesheim, 31134
Nycomed Deutschland GmbH
Hof, 95028
Nycomed Deutschland GmbH
Hofbieber, 36145
Nycomed Deutschland GmbH
Johanngeorgenstadt, 08349
Nycomed Deutschland GmbH
Karlstadt am Main, 97753
Nycomed Deutschland GmbH
Kassel, 34117
Nycomed Deutschland GmbH
Kelkheim, 65779
Nycomed Deutschland GmbH
Kiel, 24103
Nycomed Deutschland GmbH
Koblenz, 56068
Nycomed Deutschland GmbH
Kornwestheim, 70806
Nycomed Deutschland GmbH
Köthen, 06366
Nycomed Deutschland GmbH
Kronach, 96317
Nycomed Deutschland GmbH
Künzing, 94550
Nycomed Deutschland GmbH
Landstuhl, 66849
Nycomed Deutschland GmbH
Lebach, 66822
Nycomed Deutschland GmbH
Leinfelden-Echterdingen, 70771
Nycomed Deutschland GmbH
Leipzig, 04103
Nycomed Deutschland GmbH
Leipzig, 04105
Nycomed Deutschland GmbH
Leipzig, 04107
Nycomed Deutschland GmbH
Leipzig, 04129
Nycomed Deutschland GmbH
Leipzig, 04277
Nycomed Deutschland GmbH
Leisnig, 04703
Nycomed Deutschland GmbH
Leverkusen, 51375
Nycomed Deutschland GmbH
Lichtenfels, 96215
Nycomed Deutschland GmbH
Lingen, 49809
Nycomed Deutschland GmbH
Lübeck, 23552
Nycomed Deutschland GmbH
Lübeck, 23560
Nycomed Deutschland GmbH
Lüdenscheid, 58507
Nycomed Deutschland GmbH
Ludwigsburg, 71640
Nycomed Deutschland GmbH
Ludwigsfelde, 14974
Nycomed Deutschland GmbH
Ludwigshafen, 67071
Nycomed Deutschland GmbH
Ludwigslust, 19288
Nycomed Deutschland GmbH
Lüneburg, 21335
Nycomed Deutschland GmbH
Lützen, 06686
Nycomed Deutschland GmbH
Magdeburg, 39130
Nycomed Deutschland GmbH
Mainz, 55116
Nycomed Deutschland GmbH
Mannheim, 68165
Nycomed Deutschland GmbH
Mannheim, 68309
Nycomed Deutschland GmbH
Marburg, 35037
Nycomed Deutschland GmbH
Marienberg, 09496
Nycomed Deutschland GmbH
Marl, 45772
Nycomed Deutschland GmbH
Mayen, 56727
Nycomed Deutschland GmbH
Merseburg, 06217
Nycomed Deutschland GmbH
Merzig, 66663
Nycomed Deutschland GmbH
Minden, 32423
Nycomed Deutschland GmbH
Minden, 32427
Nycomed Deutschland GmbH
Möckmühl, 74219
Nycomed Deutschland GmbH
Mönchengladbach, 41236
Nycomed Deutschland GmbH
München, 80331
Nycomed Deutschland GmbH
München, 80337
Nycomed Deutschland GmbH
München, 81369
Nycomed Deutschland GmbH
München, 81545
Nycomed Deutschland GmbH
München, 81673
Nycomed Deutschland GmbH
Münzenberg, 35516
Nycomed Deutschland GmbH
Neckargemünd, 69151
Nycomed Deutschland GmbH
Neu Wulmstorf, 21629
Nycomed Deutschland GmbH
Neu-Isenburg, 63263
Nycomed Deutschland GmbH
Neubiberg, 85579
Nycomed Deutschland GmbH
Neukirchen, 08459
Nycomed Deutschland GmbH
Neustadt, 01844
Nycomed Deutschland GmbH
Neuwied, 56564
Nycomed Deutschland GmbH
Nieder-Olm, 55268
Nycomed Deutschland GmbH
Nienburg, 06429
Nycomed Deutschland GmbH
Nordhorn, 48529
Nycomed Deutschland GmbH
Nuremberg, 90403
Nycomed Deutschland GmbH
Nuremberg, 90439
Nycomed Deutschland GmbH
Nuremberg, 90473
Nycomed Deutschland GmbH
Oberhausen, 46045
Nycomed Deutschland GmbH
Oberndorf, 78727
Nycomed Deutschland GmbH
Ochsenfurt, 97199
Nycomed Deutschland GmbH
Oelsnitz, 09376
Nycomed Deutschland GmbH
Oschatz, 04758
Nycomed Deutschland GmbH
Oschersleben, 39387
Nycomed Deutschland GmbH
Osnabrück, 49078
Nycomed Deutschland GmbH
Paderborn, 33098
Nycomed Deutschland GmbH
Papenburg, 26871
Nycomed Deutschland GmbH
Peine, 31224
Nycomed Deutschland GmbH
Penig, 09322
Nycomed Deutschland GmbH
Pfullingen, 72793
Nycomed Deutschland GmbH
Pirna, 01796
Nycomed Deutschland GmbH
Plauen, 08523
Nycomed Deutschland GmbH
Plauen, 08525
Nycomed Deutschland GmbH
Potsdam, 14471
Nycomed Deutschland GmbH
Potsdam, 14480
Nycomed Deutschland GmbH
Recklinghausen, 45659
Nycomed Deutschland GmbH
Regensburg, 93059
Nycomed Deutschland GmbH
Reichenbach, 08468
Nycomed Deutschland GmbH
Remscheid, 42859
Nycomed Deutschland GmbH
Rendsburg, 24768
Nycomed Deutschland GmbH
Reutlingen, 72764
Nycomed Deutschland GmbH
Riesa, 01587
Nycomed Deutschland GmbH
Roetgen, 52159
Nycomed Deutschland GmbH
Rostock, 18147
Nycomed Deutschland GmbH
Rottach-Egern, 83700
Nycomed Deutschland GmbH
Rottweil, 78628
Nycomed Deutschland GmbH
Saarbrücken, 66111
Nycomed Deutschland GmbH
Saarlouis, 66740
Nycomed Deutschland GmbH
Saint Blasien, 79837
Nycomed Deutschland GmbH
Salzgitter, 38259
Nycomed Deutschland GmbH
Salzmünde, 06198
Nycomed Deutschland GmbH
Sangerhausen, 06526
Nycomed Deutschland GmbH
Sarstedt, 31157
Nycomed Deutschland GmbH
Schiffweiler, 66578
Nycomed Deutschland GmbH
Schmalkalden, 98574
Nycomed Deutschland GmbH
Schönwalde-Glien, 14621
Nycomed Deutschland GmbH
Schwäbisch Hall, 74523
Nycomed Deutschland GmbH
Schwedt, 16303
Nycomed Deutschland GmbH
Schwerin, 19053
Nycomed Deutschland GmbH
Siegen, 57074
Nycomed Deutschland GmbH
Sinsheim, 74889
Nycomed Deutschland GmbH
Spaichingen, 78549
Nycomed Deutschland GmbH
Steinfurt, 48565
Nycomed Deutschland GmbH
Steißlingen, 78256
Nycomed Deutschland GmbH
Stockach, 78333
Nycomed Deutschland GmbH
Strausberg, 15344
Nycomed Deutschland GmbH
Stuhr, 28816
Nycomed Deutschland GmbH
Sundern, 59846
Nycomed Deutschland GmbH
Teuchern, 06682
Nycomed Deutschland GmbH
Tönisvorst, 47918
Nycomed Deutschland GmbH
Travemünde, 23570
Nycomed Deutschland GmbH
Trier, 54292
Nycomed Deutschland GmbH
Trittau, 22946
Nycomed Deutschland GmbH
Varel, 26316
Nycomed Deutschland GmbH
Waghäusel, 68753
Nycomed Deutschland GmbH
Wangen, 88239
Nycomed Deutschland GmbH
Wanzleben, 39164
Nycomed Deutschland GmbH
Wäschenbeuren, 73116
Nycomed Deutschland GmbH
Weißwasser, 02943
Nycomed Deutschland GmbH
Westerkappeln, 49492
Nycomed Deutschland GmbH
Weyhe, 28844
Nycomed Deutschland GmbH
Wiesbaden, 65183
Nycomed Deutschland GmbH
Wiesbaden, 65185
Nycomed Deutschland GmbH
Wiesbaden, 65187
Nycomed Deutschland GmbH
Wiesloch, 69168
Nycomed Deutschland GmbH
Willich, 47877
Nycomed Deutschland GmbH
Winsen, 21423
Nycomed Deutschland GmbH
Wismar, 23966
Nycomed Deutschland GmbH
Wittenberg, 06886
Nycomed Deutschland GmbH
Wittstock, 16909
Nycomed Deutschland GmbH
Wolfsburg, 38440
Nycomed Deutschland GmbH
Worms, 67547
Nycomed Deutschland GmbH
Würzburg, 97070
Nycomed Deutschland GmbH
Zerbst, 39261
Nycomed Deutschland GmbH
Zweibrücken, 66482
Nycomed Deutschland GmbH
Zwickau, 08056
About this study
Official title: Pantoprazole 20 mg/40 mg for the Treatment of Gastroesophageal Reflux Disease (GERD)
The aim of the study was to evaluate the effect of 7 days treatment with Pantoprazole 40 mg and 20 mg on symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease) in clinical practice. During the study, the patients had to complete a short version of a patient-orientated, self-assessed reflux questionnaire (ReQuest™ in Practice).
- Conditions
- Gastroesophageal Reflux Disease
- Being tested
- Pantoprazole
- Keywords
- PPI (Proton Pump Inhibitor) therapy, Pantoprazole, eGERD (Erosive Gastroesophageal Reflux Disease), NERD (Non-Erosive Reflux Disease)
- Medical subject headings
- Gastroesophageal Reflux, Non-Erosive Reflux Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
PantoprazoleDrug
Observational, non-interventional study (NIS). The physician decided about dosage according to individual needs (20 or 40 mg pantoprazole, once daily).
| Study group | Role | What they receive |
|---|---|---|
| Pantoprazole | All patients enrolled Receives: Drug: Pantoprazole |
What is being measured
The primary outcome is the main question the study is designed to answer.
Patient's Assessment of General Well-being During the Last 24 Hours (Diaries; ReQuest™ in Practice)
Assessment on a scale: Severity from 0=Excellent to 10=Extremely bad
Measured: 7 days
Patient's Assessment of Acid Complaints During the Last 24 Hours (Diaries; ReQuest™ in Practice)
Assessment on a scale: Severity from 0=None to 10=Extremely strong
Measured: 7 days
Patient's Assessment of Upper Abdominal/Stomach Complaints During the Last 24 Hours (Diaries; ReQuest™ in Practice)
Assessment on a scale: Severity from 0=None to 10=Extremely strong
Measured: 7 days
Patient's Assessment of Lower Abdominal/Digestive Complaints During the Last 24 Hours (Diaries; ReQuest™ in Practice)
Assessment on a scale: Severity from 0=None to 10=Extremely strong
Measured: 7 days
Patient's Assessment of Nausea During the Last 24 Hours (Diaries; ReQuest™ in Practice)
Assessment on a scale: Severity from 0=None to 10=Extremely strong
Measured: 7 days
Patient's Assessment of Sleep Disturbances During the Last 24 Hours (Diaries; ReQuest™ in Practice)
Assessment on a scale: Severity from 0=None to 10=Extremely strong
Measured: 7 days
Secondary outcomes (5)
Physician's Assessment of Heartburn
Assessment on a scale: 1=none, 2=mild, 3=moderate, 4=severe
Measured: 7 days
Physician's Assessment of Acid Eructation
Assessment on a scale: 1=none, 2=mild, 3=moderate, 4=severe
Measured: 7 days
Physician's Assessment of Painful Swallowing
Assessment on a scale: 1=none, 2=mild, 3=moderate, 4=severe
Measured: 7 days
Assessment of the Efficacy of Pantoprazole 20 mg/40 mg at Final Visit
Assessment on a scale: 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory
Measured: 7 days
Assessment of the Tolerability of Pantoprazole 20 mg/40 mg at Final Visit
Assessment on a scale: 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory
Measured: 7 days
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted21 Nov 2007 (estimated)
- Study startOct 2007
- Study completionDec 2008
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Posted resultsParticipant flow, outcome measures and adverse events reported by the sponsor.
- Other trials for Gastroesophageal Reflux DiseaseStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case only
- Time perspective
- Prospective
- Enrolment
- 1,995 participants (actual)
Sponsor and investigators
- Lead sponsor
- Nycomed
- Sponsor type
- Industry (pharma, biotech, devices)
- Investigators
- Dr. Thomas D. Bethke, MD, MBA, Study director, Nycomed Deutschland GmbH, 78467 Konstanz, Germany
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT00561730
- Sponsor's protocol ID
- PAN 20/40 Panther 07/10
- Acronym
- PANTHER
- Status last verified
- May 2012
- First submitted
- 12 Nov 2007
- Last updated
- 8 May 2012
- Results posted
- Yes, on ClinicalTrials.gov
- Data monitoring committee
- No
Study at a glance
From the registry record, last updated by the sponsor on 8 May 2012. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Pantoprazole 20 mg/40 mg for the Treatment of Gastroesophageal Reflux Disease (GERD)
- ClinicalTrials.gov ID
- NCT00561730
- Acronym / sponsor ID
- PANTHER / PAN 20/40 Panther 07/10
- Conditions
- Gastroesophageal Reflux Disease
- Keywords
- PPI (Proton Pump Inhibitor) therapy, Pantoprazole, eGERD (Erosive Gastroesophageal Reflux Disease), NERD (Non-Erosive Reflux Disease)
- Study type
- Observational
- Recruitment status
- Completed
- Enrolment
- 1,995 participants (actual)
- Lead sponsor
- NycomedIndustry (pharma, biotech, devices)
- Study start
- Oct 2007
- Study completion
- Dec 2008 (actual)
- First posted
- 21 Nov 2007 (estimated)
- Results
- Posted 16 Sep 2010
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The aim of the study was to evaluate the effect of 7 days treatment with Pantoprazole 40 mg and 20 mg on symptoms in patients with NERD (non-erosive reflux disease) or eGERD (erosive gastroesophageal reflux disease) in clinical practice. During the study, the patients had to complete a short version of a patient-orientated, self-assessed reflux questionnaire (ReQuest™ in Practice).
Study design
- Observational model
- Case only
- Time perspective
- Prospective
- Number of arms
- 1
| Arm | Type | Receives |
|---|---|---|
| Pantoprazole | – | Drug: PantoprazoleAll patients enrolled |
Who may qualify
- Ages
- 12 years and older
- Sex
- All
- Healthy volunteers
- Not accepted
- Age groups
- Child, Adult, Older adult
- Study population
- Outpatients
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| PantoprazoleObservational, non-interventional study (NIS). The physician decided about dosage according to individual needs (20 or 40 mg pantoprazole, once daily). | Drug | Pantoprazole |
Primary outcome
Patient's Assessment of General Well-being During the Last 24 Hours (Diaries; ReQuest™ in Practice)
Time frame: 7 days
Assessment on a scale: Severity from 0=Excellent to 10=Extremely bad
Patient's Assessment of Acid Complaints During the Last 24 Hours (Diaries; ReQuest™ in Practice)
Time frame: 7 days
Assessment on a scale: Severity from 0=None to 10=Extremely strong
Patient's Assessment of Upper Abdominal/Stomach Complaints During the Last 24 Hours (Diaries; ReQuest™ in Practice)
Time frame: 7 days
Assessment on a scale: Severity from 0=None to 10=Extremely strong
Patient's Assessment of Lower Abdominal/Digestive Complaints During the Last 24 Hours (Diaries; ReQuest™ in Practice)
Time frame: 7 days
Assessment on a scale: Severity from 0=None to 10=Extremely strong
Patient's Assessment of Nausea During the Last 24 Hours (Diaries; ReQuest™ in Practice)
Time frame: 7 days
Assessment on a scale: Severity from 0=None to 10=Extremely strong
Patient's Assessment of Sleep Disturbances During the Last 24 Hours (Diaries; ReQuest™ in Practice)
Time frame: 7 days
Assessment on a scale: Severity from 0=None to 10=Extremely strong
5 secondary outcomes
Physician's Assessment of Heartburn
Time frame: 7 days
Physician's Assessment of Acid Eructation
Time frame: 7 days
Physician's Assessment of Painful Swallowing
Time frame: 7 days
Assessment of the Efficacy of Pantoprazole 20 mg/40 mg at Final Visit
Time frame: 7 days
Assessment of the Tolerability of Pantoprazole 20 mg/40 mg at Final Visit
Time frame: 7 days
Results and safety
Loading the posted results from ClinicalTrials.gov…
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 8 May 2012.
- Posted resultsParticipant flow, baseline, all outcome measures and adverse events.
Related trials for Gastroesophageal Reflux Disease
RecruitingObservational study
A Study to Evaluate the Efficacy and Safety of Long-term Administration of K-CAB Tab./K-CAB ODT(Tegoprazan) 25 mg as Maintenance Therapy Following the Treatment of GERD
Maintenance Therapy Following Treatment for Gastroesophageal Reflux Disease(GERD)
Active, not recruitingObservational study
RETHINK REFLUX Registry
Gastroesophageal Reflux
RecruitingObservational study
Post-Marketing Surveillance to Evaluate the Safety and Effectiveness of Zastaprazan Citrate
Erosive Gastroesophageal Reflux Disease
Recruiting
Phrenoesophageal Ligament Reconstruction With Mesh
Hiatus Hernia, Gastreoesophageal Reflux Disease
Enrolling by invitation
Endoscopic Treatment of Gastroesophageal Reflux Disease
Gastro Esophageal Reflux Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Dr. Thomas D. Bethke, MD, MBA study director
Nycomed Deutschland GmbH, 78467 Konstanz, Germany
259 sites in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
An observational study of Gastroesophageal Reflux Disease, run by Nycomed at 259 sites in Germany.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 8 May 2012. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 259 sites in Germany. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Yes. Results are posted in the registry (first posted 16 Sep 2010). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Patient's Assessment of General Well-being During the Last 24 Hours (Diaries; ReQuest™ in Practice) (time frame: 7 days). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 8 May 2012; AzTrials last refreshed its copy on 8 Nov 2026.